BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND SMAD2, MADH2, 4087, ENSG00000175387, MGC34440, MGC22139, hMAD-2, MADR2, JV18-1, hSMAD2, JV18 AND Treatment
37 results:

  • 1. CDCA5 promoted cell invasion and migration by activating TGF-β1 pathway in human ovarian cancer cells.
    Zhang Q; Zhang R; Li Y; Yang X
    J Ovarian Res; 2024 Mar; 17(1):68. PubMed ID: 38539247
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. FBXO28 promotes cell proliferation, migration and invasion via upregulation of the TGF-beta1/smad2/3 signaling pathway in ovarian cancer.
    Song G; Sun Z; Chu M; Zhang Z; Chen J; Wang Z; Zhu X
    BMC Cancer; 2024 Jan; 24(1):122. PubMed ID: 38267923
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Efficacy and Clinical Significance of the Zuogui Pill on Premature ovarian Failure via the GDF-9/smad2 Pathway.
    Cen S; Qian X; Wu C; Xu X; Yang X
    Nutr Cancer; 2023; 75(2):488-497. PubMed ID: 36194038
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The miR-33a-5p/CROT axis mediates ovarian cancer cell behaviors and chemoresistance
    Li X; Gao X; Yuan J; Wang F; Xu X; Wang C; Liu H; Guan W; Zhang J; Xu G
    Front Endocrinol (Lausanne); 2022; 13():950345. PubMed ID: 36120434
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Family with sequence similarity 46 member a confers chemo-resistance to ovarian carcinoma via TGF-β/smad2 signaling.
    Liang S; Liu Y; He J; Gao T; Li L; He S
    Bioengineered; 2022 Apr; 13(4):10629-10639. PubMed ID: 35465837
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. KLF8 is activated by TGF-β1 via smad2 and contributes to ovarian cancer progression.
    Cherukunnath A; Davargaon RS; Ashraf R; Kamdar U; Srivastava AK; Tripathi PP; Chatterjee N; Kumar S
    J Cell Biochem; 2022 May; 123(5):921-934. PubMed ID: 35293014
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Silibinin exerts anti-cancer activity on human ovarian cancer cells by increasing apoptosis and inhibiting epithelial-mesenchymal transition (EMT).
    Maleki N; Yavari N; Ebrahimi M; Faisal Faiz A; Khosh Ravesh R; Sharbati A; Panji M; Lorian K; Gravand A; Abbasi M; Abazari O; Shafiee Mehr M; Eskandari Y
    Gene; 2022 May; 823():146275. PubMed ID: 35189245
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Epithelial-mesenchymal transition polarization in ovarian carcinomas from patients with high social isolation.
    Lutgendorf SK; Penedo F; Goodheart MJ; Dahmoush L; Arevalo JMG; Thaker PH; Slavich GM; Sood AK; Cole SW
    Cancer; 2020 Oct; 126(19):4407-4413. PubMed ID: 32691853
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Inhibiting of self-renewal, migration and invasion of ovarian cancer stem cells by blocking TGF-β pathway.
    Wen H; Qian M; He J; Li M; Yu Q; Leng Z
    PLoS One; 2020; 15(3):e0230230. PubMed ID: 32214328
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. TGF-β1 induces VEGF expression in human granulosa-lutein cells: a potential mechanism for the pathogenesis of ovarian hyperstimulation syndrome.
    Fang L; Li Y; Wang S; Li Y; Chang HM; Yi Y; Yan Y; Thakur A; Leung PCK; Cheng JC; Sun YP
    Exp Mol Med; 2020 Mar; 52(3):450-460. PubMed ID: 32152452
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Activin A promotes ovarian cancer cell migration by suppressing E-cadherin expression.
    Yi Y; Cheng JC; Klausen C; Leung PCK
    Exp Cell Res; 2019 Sep; 382(2):111471. PubMed ID: 31229504
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Nodal induces apoptosis and inhibits proliferation in ovarian endometriosis-clear cell carcinoma lesions.
    Miura R; Yokoi A; Matsumoto T; Oguri Y; Hashimura M; Tochimoto M; Kajita S; Saegusa M
    BMC Cancer; 2019 Apr; 19(1):308. PubMed ID: 30943930
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Platelets promote invasion and induce epithelial to mesenchymal transition in ovarian cancer cells by TGF-β signaling pathway.
    Guo Y; Cui W; Pei Y; Xu D
    Gynecol Oncol; 2019 Jun; 153(3):639-650. PubMed ID: 30928020
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A Novel TGFβ Trap Blocks Chemotherapeutics-Induced TGFβ1 Signaling and Enhances Their Anticancer Activity in Gynecologic cancers.
    Zhu H; Gu X; Xia L; Zhou Y; Bouamar H; Yang J; Ding X; Zwieb C; Zhang J; Hinck AP; Sun LZ; Zhu X
    Clin Cancer Res; 2018 Jun; 24(12):2780-2793. PubMed ID: 29549162
    [No Abstract]    [Full Text] [Related]  

  • 15. A functional role of LEFTY during progesterone therapy for endometrial carcinoma.
    Fei W; Kijima D; Hashimoto M; Hashimura M; Oguri Y; Kajita S; Matsumoto T; Yokoi A; Saegusa M
    Cell Commun Signal; 2017 Dec; 15(1):56. PubMed ID: 29268772
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Growth differentiation factor 8 induces SKOV3 ovarian cancer cell migration and E-cadherin down-regulation.
    Zhao J; Klausen C; Xiong S; Cheng JC; Chang HM; Leung PC
    Cell Signal; 2016 Nov; 28(11):1615-22. PubMed ID: 27481097
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The TGFβ pathway stimulates ovarian cancer cell proliferation by increasing IGF1R levels.
    Alsina-Sanchis E; Figueras A; Lahiguera Á; Vidal A; Casanovas O; Graupera M; Villanueva A; Viñals F
    Int J Cancer; 2016 Oct; 139(8):1894-903. PubMed ID: 27299695
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Transforming growth factor-β stimulates human ovarian cancer cell migration by up-regulating connexin43 expression via smad2/3 signaling.
    Qiu X; Cheng JC; Zhao J; Chang HM; Leung PC
    Cell Signal; 2015 Oct; 27(10):1956-62. PubMed ID: 26186970
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. DDB2 modulates TGF-β signal transduction in human ovarian cancer cells by downregulating NEDD4L.
    Zhao R; Cui T; Han C; Zhang X; He J; Srivastava AK; Yu J; Wani AA; Wang QE
    Nucleic Acids Res; 2015 Sep; 43(16):7838-49. PubMed ID: 26130719
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Role of dihydrotestosterone (DHT) on TGF-β1 signaling pathway in epithelial ovarian cancer cells.
    Kohan-Ivani K; Gabler F; Selman A; Vega M; Romero C
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):47-58. PubMed ID: 26091707
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.